Computational biologist Tal Einav joins LJI faculty
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) is pleased to welcome biophysicist and immune system researcher Tal Einav, Ph.D.,
LJI-led team wins top Nucleate honors for virus vaccine development proposal
San Diego scientists work with business experts to advance dengue and Zika virus vaccine strategy
Can sugar and fat influence immune cell responses?
LA JOLLA, CA—A population of unconventional white blood cells has recently captured the attention of immunologists and clinicians alike. Unlike
Antibody responses to SARS-CoV-2 infection and vaccination
In this seminar, Florian Krammer, Ph.D. from the Mount Sinai School of Medicine, discussed antibody responses to SARS-CoV-2 and new
NATURE AND BEYOND: Fc Mediated Enhancement of Anti-Viral Antibodies
In this seminar, Dr. Jon Yewdell, M.D., Ph.D., of NIAID, covers topics related to viral protein translations, the mechanisms of
Of brains and brain trusts
A letter from LJI President and CEO Erica Ollmann Saphire, Ph.D.
Get to know John Keegan
How LJI’s new Chief Operating Officer defines “mission success”
Online exclusive: Tinkering with T cells
New innate immune system research—and a prestigious ARCS Award—could enhance future vaccines
How to build a lab
Scientists often compare starting a new lab to starting a small business. It takes finding the right people and solid funding to make the dream work. Assistant Professor Samuel Myers, Ph.D., shares an honest look at what it’s like to start a new lab at La Jolla Institute for Immunology (LJI).
